Artillery Labs is proud to announce a strategic partnership with Canna Medical, a leading cannabis enterprise in Mexico, marking a significant milestone in the expansion of CBD products within the region. This partnership heralds the registration of nine premium Cannabidiol Tinctures with the COFEPRIS, following Canna Medical’s pivotal Supreme Court Ruling in December 2023, granting them authorization to register, import, and distribute CBD-based products.
The inaugural products undergoing registration with the COFEPRIS are nine meticulously crafted cannabidiol tinctures, developed in conjunction with Cannabidiol Life, an industry-leading cannabidiol manufacturer headquartered in Florida, recognized for its unwavering dedication to excellence in the CBD sector.
Cannabidiol Life’s distinguished achievements underscore its pioneering spirit and steadfast commitment to quality:
- In 2017, Cannabidiol Life received recognition from the National Hemp Association as the preeminent resource for “CBD Education & Product Guides.”
- In 2018, the company secured the prestigious title of “Best CBD Capsules” in the nation, conferred by CBDExpo.net.
- In 2019, Cannabidiol Life garnered international acclaim, earning nominations at the esteemed World CBD Awards held in Barcelona, Spain, across categories including Best CBD Oil, Best CBD Edibles, Best CBD Innovation, and Best CBD Pet Products.
- In 2020, Cannabidiol Life achieved a historic milestone as the second United States-based CBD brand to register and certify CBD oil products with the Brazilian Government.
- In 2021, the pioneering enterprise became the inaugural United States-based CBD brand to register and certify CBD Capsule products with the Peruvian Government.
“We are thrilled to spearhead this transformative journey alongside Canna Medical and Cannabidiol Life,” expressed a spokesperson from Artillery Labs. “This partnership not only underscores our unwavering commitment to advancing healthcare and wellness solutions but also signifies our dedication to ensuring the accessibility of premium CBD offerings in Mexico.”
Anticipation is high as Artillery Labs eagerly awaits COFEPRIS approval, slated for the second quarter of 2024. With a shared vision of pioneering innovation and enhancing the quality of life for individuals worldwide, this partnership marks a pivotal moment in the evolution of the CBD industry, promising to unlock new avenues of wellness for communities across Mexico.